New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

by University of Eastern FinlandThe hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Easter
Neurology March 07,2024
Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

by University of Eastern FinlandThe hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Easter
Neurology March 07,2024
Research highlights misdiagnosis for people with Alzheimer's disease

Research highlights misdiagnosis for people with Alzheimer's disease

by Alzheimer's Research UKResearch presented today (Tuesday 26 July) at the Alzheimer's Association International Conference 2016 suggests that men with Alzheimer's may be more likely
Neurology March 07,2024
Research highlights misdiagnosis for people with Alzheimer's disease

Research highlights misdiagnosis for people with Alzheimer's disease

by Alzheimer's Research UKResearch presented today (Tuesday 26 July) at the Alzheimer's Association International Conference 2016 suggests that men with Alzheimer's may be more likely
Neurology March 07,2024
Researchers develop combined data model to better evaluate for mild cognitive impairment

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive
Neurology March 07,2024
Researchers develop combined data model to better evaluate for mild cognitive impairment

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive
Neurology March 07,2024
Genetic and non-genetic resilience against memory decline and Alzheimer's

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,
Neurology March 07,2024
Genetic and non-genetic resilience against memory decline and Alzheimer's

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,
Neurology March 07,2024
Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

by University of Eastern FinlandAntipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer's disease, shows a recent study from the Univer
Neurology March 07,2024
Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

by University of Eastern FinlandAntipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer's disease, shows a recent study from the Univer
Neurology March 07,2024
Use of feeding tubes decreases among nursing home residents with advanced dementia

Use of feeding tubes decreases among nursing home residents with advanced dementia

by The JAMA Network JournalsIn a study appearing in the August 16 issue ofJAMA, Susan L. Mitchell, M.D., M.P.H., of Hebrew SeniorLife Institute for Aging Research, Harvard Medical School, B
Neurology March 07,2024
Use of feeding tubes decreases among nursing home residents with advanced dementia

Use of feeding tubes decreases among nursing home residents with advanced dementia

by The JAMA Network JournalsIn a study appearing in the August 16 issue ofJAMA, Susan L. Mitchell, M.D., M.P.H., of Hebrew SeniorLife Institute for Aging Research, Harvard Medical School, B
Neurology March 07,2024
Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne
Neurology March 07,2024
Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne
Neurology March 07,2024
Statin use reduces mortality and stroke risk in dementia patients, new study shows

Statin use reduces mortality and stroke risk in dementia patients, new study shows

by The European Academy of NeurologyThe use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Acad
Neurology March 07,2024
Statin use reduces mortality and stroke risk in dementia patients, new study shows

Statin use reduces mortality and stroke risk in dementia patients, new study shows

by The European Academy of NeurologyThe use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Acad
Neurology March 07,2024
Long-term use of opioid patches common among persons with Alzheimer's disease

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a
Neurology March 07,2024
Long-term use of opioid patches common among persons with Alzheimer's disease

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a
Neurology March 07,2024
Can older adults with dementia continue to drive? More study is needed

Can older adults with dementia continue to drive? More study is needed

by American Geriatrics SocietyHow do you know when it's time for an older adult with mild dementia to stop driving? Dementia is a general term for a decline in mental ability severe enough to inte
Neurology March 07,2024
Can older adults with dementia continue to drive? More study is needed

Can older adults with dementia continue to drive? More study is needed

by American Geriatrics SocietyHow do you know when it's time for an older adult with mild dementia to stop driving? Dementia is a general term for a decline in mental ability severe enough to inte
Neurology March 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com